News: C R Bard Inc (BCR)

BCR on New York Consolidated

175.13USD
27 Apr 2015
Change (% chg)

$-0.25 (-0.14%)
Prev Close
$175.38
Open
$176.27
Day's High
$177.00
Day's Low
$174.31
Volume
142,775
Avg. Vol
628,231
52-wk High
$180.94
52-wk Low
$134.34

Search Stocks
Select another date:

Tue, Feb 17 2015

C.R. Bard settles bellwether case over transvaginal mesh

- C.R. Bard has settled a lawsuit selected to serve as a bellwether trial in multidistrict litigation over transvaginal mesh devices, which had been scheduled to start this week.

RPT-Boston Scientific faces first federal transvaginal mesh trials

Nov 3 - Boston Scientific Corp on Monday was set to face its first federal trials in two courts over claims from women who say they were injured by the company's transvaginal mesh devices.

Boston Scientific faces first federal transvaginal mesh trials

- Boston Scientific Corp on Monday was set to face its first federal trials in two courts over claims from women who say they were injured by the company’s transvaginal mesh devices.

Boston Scientific faces first federal transvaginal mesh trials

Nov 3 - Boston Scientific Corp on Monday was set to face its first federal trials in two courts over claims from women who say they were injured by the company's transvaginal mesh devices.

Select another date:
Search Stocks